Clinical Trials
29 trialsLongitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma
Medical University of Vienna
Uveal Melanoma - Comparative Study
Medical University of Vienna
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
M.D. Anderson Cancer Center
SALOME Quali
Institut Curie
MicroGenUM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma
Hoosier Cancer Research Network
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
California Pacific Medical Center Research Institute
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
ISABELLA
MelanomaPRO, Russia
The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
University of Catania
ICIPRESIST19
Russian Academy of Medical Sciences
PULSE-UM
Institut d'Investigació Biomèdica de Bellvitge
Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
California Pacific Medical Center Research Institute
BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma
Greater Houston Retina Research
The Role of Inflammation in Ocular Tumours
Unity Health Toronto
TCR
The Netherlands Cancer Institute
TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy
Charite University, Berlin, Germany
STREAM
University Hospital, Essen
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
National Cancer Institute (NCI)
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
National Cancer Institute (NCI)
TORR
Leiden University Medical Center
Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma
Medical University of Vienna
Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma
Barnes Retina Institute
Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
Shields, Shields and Associates
Study of Metastatic Ocular Melanoma
Charite University, Berlin, Germany
Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
Ludwig-Maximilians - University of Munich
Collaborative Ocular Melanoma Study (COMS)
National Eye Institute (NEI)
Pain Relief - Tramadol Versus Ibuprofen
Royal Liverpool University Hospital